Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silke Duensing-Kropp

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
RSC Medicinal Chemistry|August 18, 2025
Fragment-based discovery of dual ligand pharmacophores for lipid-sensing transcription factors for designed polypharmacologyTanja Stiller, Silke Duensing-Kropp, Julian A Marschner, et al.
Chemmedchem|September 12, 2023
Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer AgonismDaniel Zaienne, Laura Isigkeit, Julian A Marschner, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2022
Nurr1 Modulation Mediates Neuroprotective Effects of StatinsSabine Willems, Julian A Marschner, Whitney Kilu, et al.
Journal of Medicinal Chemistry|May 8, 2025
A First-in-Class Hepatocyte Nuclear Factor 4 AgonistEspen Schallmayer, Vasily Morozov, Silke Duensing-Kropp, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
RSC Medicinal Chemistry|August 18, 2025
Fragment-based discovery of dual ligand pharmacophores for lipid-sensing transcription factors for designed polypharmacologyTanja Stiller, Silke Duensing-Kropp, Julian A Marschner, et al.
Chemmedchem|September 12, 2023
Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer AgonismDaniel Zaienne, Laura Isigkeit, Julian A Marschner, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 30, 2022
Nurr1 Modulation Mediates Neuroprotective Effects of StatinsSabine Willems, Julian A Marschner, Whitney Kilu, et al.
Journal of Medicinal Chemistry|May 8, 2025
A First-in-Class Hepatocyte Nuclear Factor 4 AgonistEspen Schallmayer, Vasily Morozov, Silke Duensing-Kropp, et al.
Pageof 1